Athenex's Unattributed - III Round

Athenex raised a round of funding on June 16, 2015.

Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases an…

Articles about Athenex's Unattributed - III Round: